Skip to main content

Fast-growing depression treatment provider continues Philadelphia-area expansion

The company, which uses on non-invasive technology developed by Malvern-based Neuronetics to treat depression, says business has grown 20% during the pandemic.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.